MORPHINAN-3,14-DIOL, 17-(3-BUTENYL)-4,5-EPOXY-6-METHYLENE-, (5.ALPHA.)-
UNII KNT5B2W6ZJ
Substance Identification & Data
This profile provides standardized clinical and technical data for Morphinan-3,14-diol, 17-(3-butenyl)-4,5-epoxy-6-methylene-, (5.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KNT5B2W6ZJ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 738552-29-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H25NO3 RBIVPGSQKYUIET-MBPVOVBZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Morphinan-3,14-diol, 17-(3-butenyl)-4,5-epoxy-6-methylene-, (5.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.